Jinsmaa Y - Search Results

1

Divalent metal ions enhance DOPAL-induced oligomerization of alpha-synuclein.

Jinsmaa Y, Sullivan P, Gross D, Cooney A, Sharabi Y, Goldstein DS. Jinsmaa Y, et al. Neurosci Lett. 2014 May 21;569:27-32. doi: 10.1016/j.neulet.2014.03.016. Epub 2014 Mar 23. Neurosci Lett. 2014. PMID: 24670480 Free PMC article.

2

The serotonin aldehyde, 5-HIAL, oligomerizes alpha-synuclein.

Jinsmaa Y, Cooney A, Sullivan P, Sharabi Y, Goldstein DS. Jinsmaa Y, et al. Neurosci Lett. 2015 Mar 17;590:134-7. doi: 10.1016/j.neulet.2015.01.064. Epub 2015 Jan 28. Neurosci Lett. 2015. PMID: 25637699 Free PMC article.

3

Rotenone decreases intracellular aldehyde dehydrogenase activity: implications for the pathogenesis of Parkinson's disease.

Goldstein DS, Sullivan P, Cooney A, Jinsmaa Y, Kopin IJ, Sharabi Y. Goldstein DS, et al. Among authors: jinsmaa y. J Neurochem. 2015 Apr;133(1):14-25. doi: 10.1111/jnc.13042. Epub 2015 Feb 25. J Neurochem. 2015. PMID: 25645689 Free PMC article.

4

Comparison of Monoamine Oxidase Inhibitors in Decreasing Production of the Autotoxic Dopamine Metabolite 3,4-Dihydroxyphenylacetaldehyde in PC12 Cells.

Goldstein DS, Jinsmaa Y, Sullivan P, Holmes C, Kopin IJ, Sharabi Y. Goldstein DS, et al. Among authors: jinsmaa y. J Pharmacol Exp Ther. 2016 Feb;356(2):483-92. doi: 10.1124/jpet.115.230201. Epub 2015 Nov 16. J Pharmacol Exp Ther. 2016. PMID: 26574516 Free PMC article.

5

DOPAL is transmissible to and oligomerizes alpha-synuclein in human glial cells.

Jinsmaa Y, Sullivan P, Sharabi Y, Goldstein DS. Jinsmaa Y, et al. Auton Neurosci. 2016 Jan;194:46-51. doi: 10.1016/j.autneu.2015.12.008. Epub 2015 Dec 31. Auton Neurosci. 2016. PMID: 26777075 Free PMC article.

6

3,4-Dihydroxyphenylethanol (Hydroxytyrosol) Mitigates the Increase in Spontaneous Oxidation of Dopamine During Monoamine Oxidase Inhibition in PC12 Cells.

Goldstein DS, Jinsmaa Y, Sullivan P, Holmes C, Kopin IJ, Sharabi Y. Goldstein DS, et al. Among authors: jinsmaa y. Neurochem Res. 2016 Sep;41(9):2173-8. doi: 10.1007/s11064-016-1959-0. Epub 2016 May 25. Neurochem Res. 2016. PMID: 27220335 Free PMC article.

7

3,4-Dihydroxyphenylacetaldehyde-Induced Protein Modifications and Their Mitigation by N-Acetylcysteine.

Jinsmaa Y, Sharabi Y, Sullivan P, Isonaka R, Goldstein DS. Jinsmaa Y, et al. J Pharmacol Exp Ther. 2018 Jul;366(1):113-124. doi: 10.1124/jpet.118.248492. Epub 2018 Apr 26. J Pharmacol Exp Ther. 2018. PMID: 29700232 Free PMC article.

8

3,4-Dihydroxyphenylacetaldehyde Is More Efficient than Dopamine in Oligomerizing and Quinonizing α-Synuclein.

Jinsmaa Y, Isonaka R, Sharabi Y, Goldstein DS. Jinsmaa Y, et al. J Pharmacol Exp Ther. 2020 Feb;372(2):157-165. doi: 10.1124/jpet.119.262246. Epub 2019 Nov 19. J Pharmacol Exp Ther. 2020. PMID: 31744850 Free PMC article.

9

Vesicular uptake blockade generates the toxic dopamine metabolite 3,4-dihydroxyphenylacetaldehyde in PC12 cells: relevance to the pathogenesis of Parkinson's disease.

Goldstein DS, Sullivan P, Cooney A, Jinsmaa Y, Sullivan R, Gross DJ, Holmes C, Kopin IJ, Sharabi Y. Goldstein DS, et al. Among authors: jinsmaa y. J Neurochem. 2012 Dec;123(6):932-43. doi: 10.1111/j.1471-4159.2012.07924.x. Epub 2012 Oct 25. J Neurochem. 2012. PMID: 22906103 Free PMC article.

10

Benomyl, aldehyde dehydrogenase, DOPAL, and the catecholaldehyde hypothesis for the pathogenesis of Parkinson's disease.

Casida JE, Ford B, Jinsmaa Y, Sullivan P, Cooney A, Goldstein DS. Casida JE, et al. Among authors: jinsmaa y. Chem Res Toxicol. 2014 Aug 18;27(8):1359-61. doi: 10.1021/tx5002223. Epub 2014 Jul 24. Chem Res Toxicol. 2014. PMID: 25045800 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

54 results

Search Page